(Reuters) - Canada's main stock index dipped on Monday on weak data from China, though a jump in healthcare stocks led by cannabis producer Canopy Growth limited losses.
** Canopy Growth Co jumped 12.7%, and was the biggest percentage gainer on the TSX, after the company named Constellation Brands (NYSE:STZ) Inc's Chief Financial Officer David Klein as its chief executive officer, effective Jan. 14.
** The healthcare sector jumped 3.5%, the most among the major Canadian sectors.
** China's exports in November shrank for the fourth consecutive month, underscoring persistent pressures on manufacturers from the Sino-U.S. war but growth in imports may be a sign that Beijing's stimulus steps are helping demand.
** At 9:45 a.m. ET (14:45 GMT), the Toronto Stock Exchange's S&P/TSX composite index was down 11.89 points, or 0.07 percent, at 16,985.08.
** In a quiet start to the week, market participants are expected to keep a close watch on trade as planned U.S. tariffs on Chinese imports kick in on Dec. 15 that will cover several consumer products, including mobile phones and toys.
** On the TSX, 82 issues were higher, while 138 issues declined for a 1.68-to-1 ratio to the downside, with 16.07 million shares traded.
** Turquoise Hill Resources Ltd fell 2.5%, the most on the TSX, while the second biggest decliner was Frontera Energy Corp, which fell 2.4%.
** The most heavily traded shares by volume were Aurora Cannabis Inc, Canopy Growth and Star Diamond Corp.
** The TSX posted three new 52-week highs and no new low.
** Across all Canadian issues there were 17 new 52-week highs and nine new lows, with total volume of 32.13 million shares.